title: Grape seed proanthocyanidins and metformin act by different mechanisms to promote insulin signaling in rats fed high calorie diet.
abstract: Key pathways like insulin signaling, AMP activated kinase (AMPK) activation and inflammatory signaling are involved in the complex pathological network of hepatic insulin resistance. Our aim is to investigate whether grape seed proanthocyanidins (GSP) and metformin (MET) target any of these pathways in insulin resistant rat liver. Albino Wistar rats were rendered insulin resistant by feeding a high fat-fructose diet (HFFD). Either GSP (100 mg/kg b.w), MET(50 mg/kg b.w) or both were administered to insulin resistant rats as therapeutic options. HFFD-feeding caused hyperglycemia, hyperinsulinemia, increased gluconeogenesis, decreased tyrosine phosphorylation of insulin receptor-β(IR-β) and insulin receptor substrate-1 (IRS-1) and increased serine phosphorylation of IRS-1. The association of p85α subunit of phosphotidyl inositol 3 kinase(PI3K) with IRS-1 and subsequent Akt phosphorylation were reduced while the expression of mitogen activated protein kinases (MAPK) were increased in HFFD rats. Both MET and GSP reduced hyperglycemia and hyperinsulinemia and improved glycolysis, tyrosine phosphorylation of IR-β and IRS-1, IRS-1-PI3K association and Akt activation. However, activation of tumor necrosis factor-α, interleukin-6, leptin and suppressor of cytokine signaling-3 and reduction in adiponectin caused by chronic HFFD feeding were reversed by GSP better than by MET. Activation of AMPK by GSP was much less compared to that by MET. These findings suggest that GSP might activate PI3K pathway and promote insulin action by reducing serine kinase activation and cytokine signaling and MET by targeting AMPK. The beneficial effects were enhanced during combination therapy. Thus, combination therapy with MET and GSP may be considered for the management of metabolic syndrome.
authors.affiliation: Department of Biochemistry and Biotechnology, Annamalai University, Annamalai Nagar, 608 002, Tamil Nadu, India.
authors.forename: Baskaran
authors.initials: B
authors.lastname: Yogalakshmi
authors.forename: Saravanan
authors.initials: S
authors.lastname: Bhuvaneswari
authors.forename: S
authors.initials: S
authors.lastname: Sreeja
authors.forename: Carani Venkatraman
authors.initials: CV
authors.lastname: Anuradha
references.citation: Food Chem Toxicol. 2010 Jul;48(7):1853-7
references.pmid: 20412828
references.citation: Endocrinology. 2005 Jun;146(6):2726-35
references.pmid: 15746249
references.citation: J Nutr Biochem. 2010 Jun;21(6):476-81
references.pmid: 19443198
references.citation: Nat Rev Mol Cell Biol. 2006 Feb;7(2):85-96
references.pmid: 16493415
references.citation: Diabetes Care. 2013 Jun;36(6):1454-61
references.pmid: 23275372
references.citation: J Exp Med. 1997 Jan 6;185(1):171-5
references.pmid: 8996253
references.citation: J Biol Chem. 2000 Dec 22;275(51):40649-57
references.pmid: 11018044
references.citation: J Biochem Mol Biol Biophys. 2002 Apr;6(2):129-33
references.pmid: 12186769
references.citation: J Nutr Biochem. 2009 Mar;20(3):210-8
references.pmid: 18602813
references.citation: FEBS Lett. 2003 Jul 3;546(1):32-6
references.pmid: 12829233
references.citation: Biochemistry. 1996 Jul 2;35(26):8769-75
references.pmid: 8679641
references.citation: Mol Med. 2008 Nov-Dec;14(11-12):741-51
references.pmid: 19009016
references.citation: J Clin Invest. 2001 Oct;108(8):1167-74
references.pmid: 11602624
references.citation: FEBS Lett. 2005 Jan 17;579(2):295-301
references.pmid: 15642335
references.citation: Curr Hypertens Rep. 2008 Apr;10(2):156-64
references.pmid: 18474184
references.citation: Am J Clin Nutr. 2006 Feb;83(2):461S-465S
references.pmid: 16470013
references.citation: Diabetes Obes Metab. 2006 May;8(3):264-80
references.pmid: 16634986
references.citation: Am J Physiol. 1999 Jul;277(1):E1-10
references.pmid: 10409121
references.citation: Mol Cell Biol. 2004 Jun;24(12):5434-46
references.pmid: 15169905
references.citation: J Int Med Res. 2011;39(5):1876-82
references.pmid: 22117989
references.citation: J Biol Chem. 2000 Mar 24;275(12):9047-54
references.pmid: 10722755
references.citation: Diabetes Obes Metab. 2005 Nov;7(6):633-41
references.pmid: 16219007
references.citation: Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6194-202
references.pmid: 17062697
references.citation: J Biol Chem. 2004 Aug 20;279(34):35298-305
references.pmid: 15199052
references.citation: Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E887-98
references.pmid: 20823448
references.citation: J Biol Chem. 1951 Nov;193(1):265-75
references.pmid: 14907713
references.citation: J Clin Endocrinol Metab. 2004 Jun;89(6):2548-56
references.pmid: 15181022
references.citation: Int J Clin Pract. 2004 Sep;58(9):867-76
references.pmid: 15529521
references.citation: Food Chem Toxicol. 2009 Jun;47(6):1176-1183
references.pmid: 19425235